308 related articles for article (PubMed ID: 16280334)
1. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
2. The implications of weight changes with antipsychotic treatment.
Sussman N
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
[TBL] [Abstract][Full Text] [Related]
3. The role of lifestyle interventions and weight management in schizophrenia.
Bushe C; Haddad P; Peveler R; Pendlebury J
J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
[TBL] [Abstract][Full Text] [Related]
4. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
5. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
6. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
7. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
8. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
9. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
10. Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia.
Hutton SB; Crawford TJ; Gibbins H; Cuthbert I; Barnes TR; Kennard C; Joyce EM
Psychopharmacology (Berl); 2001 Sep; 157(3):284-91. PubMed ID: 11605084
[TBL] [Abstract][Full Text] [Related]
11. Weight changes during clozapine treatment.
Briffa D; Meehan T
Aust N Z J Psychiatry; 1998 Oct; 32(5):718-21. PubMed ID: 9805596
[TBL] [Abstract][Full Text] [Related]
12. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
Himmerich H; Schuld A; Pollmächer T
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
Rege S
Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].
Cordes J; Sinha-Röder A; Kahl KG; Malevani J; Thuenker J; Lange-Asschenfeldt C; Hauner H; Agelink MW; Klimke A
Fortschr Neurol Psychiatr; 2008 Dec; 76(12):703-14. PubMed ID: 18924059
[TBL] [Abstract][Full Text] [Related]
15. The clinical implications of weight gain in schizophrenia.
Kurzthaler I; Fleischhacker WW
J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
[TBL] [Abstract][Full Text] [Related]
16. Naturalistic impact of second-generation antipsychotics on weight gain.
Brixner DI; Said Q; Corey-Lisle PK; Tuomari AV; L'italien GJ; Stockdale W; Oderda GM
Ann Pharmacother; 2006 Apr; 40(4):626-32. PubMed ID: 16569802
[TBL] [Abstract][Full Text] [Related]
17. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-associated weight gain and clinical outcome parameters.
Blin O; Micallef J
J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia, obesity, and antipsychotic medications: what can we do?
Citrome L; Vreeland B
Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
[TBL] [Abstract][Full Text] [Related]
20. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]